Quality is our promise.

Call us today! 1-888-502-2050

1

May
2015
PRESS
RELEASE

KRS Global Announces the Immediate Availability of A Lyophilized & Sterile, Compounded L-Asparaginase Preparation

Boca Raton, FL: KRS Global Biotechnology (KRS-GBT), FDA Registered Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to reveal it has developed a sterile, lyophilized L-Asparaginase preparation. FOR IMMEDIATE RELEASE Sterile L-Asparaginase Available in Three Different Concentrations Boca Raton, FL., November 18, 2014 – “What the […]

1

May
2015
PRESS
RELEASE

KRS Global Biotechnology Announces New Oral Rinse

Boca Raton, FL: KRS Global Biotechnology (KRS/GBTRx), Premier Compounding Pharmacy and FDA Registered Human Drug Compounding Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to announce an addition to their already extensive lines: an Oral Rinse formulated to assist with management of oral mucositis. FOR IMMEDIATE […]

1

May
2015
PRESS
RELEASE

KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.

FDA registered and inspected 503B Human Outsourcing Facility, KRS Global Biotechnology, Inc. who specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin. BOCA RATON, FL., 7 July 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it […]